Eli Lilly

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Eli Lilly 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About LLY

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products consist of diabetes, oncology, immunology, neuroscience, and other products and therapies. 

CEO
David A. Ricks
CEODavid A. Ricks
Employees
47,000
Employees47,000
Headquarters
Indianapolis, Indiana
HeadquartersIndianapolis, Indiana
Founded
1876
Founded1876
Employees
47,000
Employees47,000

LLY Key Statistics

Market cap
981.30B
Market cap981.30B
Price-Earnings ratio
50.65
Price-Earnings ratio50.65
Dividend yield
0.59%
Dividend yield0.59%
Average volume
2.88M
Average volume2.88M
High today
$1,048.37
High today$1,048.37
Low today
$1,020.00
Low today$1,020.00
Open price
$1,029.00
Open price$1,029.00
Volume
3.30M
Volume3.30M
52 Week high
$1,133.95
52 Week high$1,133.95
52 Week low
$623.78
52 Week low$623.78

Stock Snapshot

As of today, Eli Lilly(LLY) shares are valued at $1,035.88. The company's market cap stands at 981.3B, with a P/E ratio of 50.65 and a dividend yield of 58.6%.

On 2026-01-30, Eli Lilly(LLY) stock moved within a range of $1,020.00 to $1,048.37. With shares now at $1,035.88, the stock is trading +1.6% above its intraday low and -1.2% below the session's peak.

Trading volume for Eli Lilly(LLY) stock has reached 3.3M, versus its average volume of 2.88M.

Over the past 52 weeks, Eli Lilly(LLY) stock has traded between a high of $1,133.95 and a low of $623.78.

Over the past 52 weeks, Eli Lilly(LLY) stock has traded between a high of $1,133.95 and a low of $623.78.

LLY News

Nasdaq 6h
Eli Lilly Plans Major Investment In Pennsylvania To Boost Next-Generation Obesity Drugs

(RTTNews) - Pharmaceutical company Eli Lilly (LLY) has announced plans to invest more than $3.5 billion to construct a new manufacturing facility in Pennsylvani...

Eli Lilly Plans Major Investment In Pennsylvania To Boost Next-Generation Obesity Drugs
CNBC 7h
Eli Lilly CEO says Medicare coverage of obesity drugs could 'change the game' for upcoming pill launch

Key Points Eli Lilly CEO Dave Ricks said upcoming Medicare coverage of obesity drugs could be a major catalyst for the launch of the company's closely watched e...

Eli Lilly CEO says Medicare coverage of obesity drugs could 'change the game' for upcoming pill launch
Benzinga 10h
Novo Nordisk Outspends Eli Lilly On Wegovy, Ozempic Ads After Supply Crunch Eases - Benzinga

...

Novo Nordisk Outspends Eli Lilly On Wegovy, Ozempic Ads After Supply Crunch Eases - Benzinga

Analyst ratings

75%

of 32 ratings
Buy
75%
Hold
21.9%
Sell
3.1%

More LLY News

TipRanks 11h
Eli Lilly to Build $3.5 Billion Manufacturing Plant in Pennsylvania

U.S. pharmaceutical company Eli Lilly and Co. (LLY) has announced plans to invest more than $3.5 billion in a new manufacturing plant to be located in Pennsylva...

TipRanks 12h
Eli Lilly selects Pennsylvania’s Lehigh Valley for $3.5B site investment

Eli Lilly (LLY) announced plans to invest more than $3.5B in a new manufacturing facility in the Lehigh Valley, Pennsylvania. “The site will serve as Lilly’s ne...

CNBC 12h
Eli Lilly plans $3.5 billion manufacturing plant in Pennsylvania to make next-generation obesity injections

Lilly Chair and CEO Dave Ricks speaks during a press conference for Eli Lilly and Company in Houston, Texas, U.S., Sept. 23, 2025. Eli Lilly on Friday said it...

Eli Lilly plans $3.5 billion manufacturing plant in Pennsylvania to make next-generation obesity injections
The Wall Street Journal 12h
Pennsylvania Wins Bid for Eli Lilly Weight-Loss Drug Factory

A rendering of Eli Lilly's planned new manufacturing facility in Fogelsville, Pa. Lilly Drug giant Eli Lilly LLY 0.40 %increase; green up pointing triangle say...

Pennsylvania Wins Bid for Eli Lilly Weight-Loss Drug Factory
The Motley Fool 12h
FDA Decision on Eli Lilly's Weight Loss Pill Delayed to Q2. Is This Bad News for the Stock?

The target action date for orforglipron is now April 10. Eli Lilly (LLY +0.37%) has been experiencing fantastic growth due to the success of its GLP-1 drugs, M...

FDA Decision on Eli Lilly's Weight Loss Pill Delayed to Q2. Is This Bad News for the Stock?
The Motley Fool 15h
Should You Buy Eli Lilly Before Feb. 4?

Is there another beat-and-raise in the pharmaceutical giant's near future? Eli Lilly (LLY +0.03%), the largest healthcare company in the world, will report its...

Should You Buy Eli Lilly Before Feb. 4?
Simply Wall St 17h
Eli Lilly Extends Beyond GLP 1 With Gene Editing And Cancer Push

Eli Lilly (NYSE:LLY) agreed to work with Seamless Therapeutics on gene editing therapies for hearing loss. The company entered a research agreement with Repert...

Eli Lilly Extends Beyond GLP 1 With Gene Editing And Cancer Push

People also own

Based on the portfolios of people who own LLY. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.